Revenue Reached HK$ 273.8M, Driven by Solid Growth from Bogutai® Innovation-Driven Transformation Progresses with Portfolio Optimization and Broader Market Access HONG KONG SAR – EQS Newswire – 26 August 2026 – A fully integrated biopharmaceutical company...
Upgrade to Argentina site allows doubling of whey permeate powder capacity and production of infant formula-grade proteinsCOPENHAGEN, DENMARK - Media OutReach -...